Lincluden Management Ltd. Boosts Stock Position in UnitedHealth Group Incorporated $UNH

Lincluden Management Ltd. boosted its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 73.1% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 14,408 shares of the healthcare conglomerate’s stock after purchasing an additional 6,084 shares during the quarter. Lincluden Management Ltd.’s holdings in UnitedHealth Group were worth $4,495,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Vanguard Group Inc. grew its position in shares of UnitedHealth Group by 6.6% in the 1st quarter. Vanguard Group Inc. now owns 90,729,585 shares of the healthcare conglomerate’s stock worth $47,519,620,000 after acquiring an additional 5,583,343 shares in the last quarter. Wellington Management Group LLP grew its position in shares of UnitedHealth Group by 10.6% in the 1st quarter. Wellington Management Group LLP now owns 25,847,940 shares of the healthcare conglomerate’s stock worth $13,537,859,000 after acquiring an additional 2,486,839 shares in the last quarter. Bank of New York Mellon Corp grew its position in shares of UnitedHealth Group by 2.5% in the 1st quarter. Bank of New York Mellon Corp now owns 8,128,174 shares of the healthcare conglomerate’s stock worth $4,257,131,000 after acquiring an additional 196,696 shares in the last quarter. Nuveen LLC acquired a new position in shares of UnitedHealth Group in the 1st quarter worth approximately $3,846,764,000. Finally, Charles Schwab Investment Management Inc. grew its position in shares of UnitedHealth Group by 13.6% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 7,070,385 shares of the healthcare conglomerate’s stock worth $3,702,736,000 after acquiring an additional 847,054 shares in the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Stock Down 3.6%

Shares of UnitedHealth Group stock opened at $354.30 on Friday. The business’s fifty day moving average price is $318.21 and its two-hundred day moving average price is $349.25. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The company has a market capitalization of $320.88 billion, a P/E ratio of 15.35, a PEG ratio of 2.29 and a beta of 0.47. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The firm had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. During the same period in the prior year, the firm posted $6.80 EPS. The firm’s quarterly revenue was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were paid a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date of this dividend was Monday, September 15th. UnitedHealth Group’s payout ratio is currently 38.30%.

Analysts Set New Price Targets

A number of research analysts recently issued reports on UNH shares. Wells Fargo & Company boosted their price objective on UnitedHealth Group from $267.00 to $400.00 and gave the company an “overweight” rating in a research report on Tuesday, October 7th. Barclays boosted their price objective on UnitedHealth Group from $352.00 to $386.00 and gave the company an “overweight” rating in a research report on Thursday. Morgan Stanley boosted their price objective on UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a research report on Friday, September 12th. Weiss Ratings restated a “sell (d+)” rating on shares of UnitedHealth Group in a research report on Wednesday. Finally, Bank of America boosted their price objective on UnitedHealth Group from $350.00 to $390.00 and gave the company a “neutral” rating in a research report on Wednesday. Sixteen analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have issued a Sell rating to the company. According to data from MarketBeat, UnitedHealth Group currently has an average rating of “Hold” and a consensus price target of $383.09.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.